Reply To: Traders Market Weekly: Fed Psychosis Reaches Next Level


Oracle (ORCL 75.25, -1.40): -1.8% after missing EPS estimates, even as the company guided fiscal Q4 EPS and revenue above consensus.
DocuSign (DOCU 77.70, -16.18): -17.2% after guiding revenue for fiscal Q1 and FY23 below consensus, outweighing the company’s revenue beat and share buyback authorization of up to $200 million.
Rivian (RIVN 37.80, -3.36): -8.2% after missing top and bottom-line estimates. The company guided for FY22 production of 25,000 vehicles.
Ulta Beauty (ULTA 387.50, +8.13): +2.1% after beating revenue estimates and authorizing a new $2.0 billion share repurchase program.
Chevron (CVX 166.70, -4.12): -2.4% after the stock was downgraded to Underweight from Neutral at JP Morgan.
Applied Materials (AMAT 129.25, +4.28): +3.4% after announcing a new $6 billion share repurchase authorization and increasing its cash dividend by 8.3%.